13F HOLDINGS REPORT
SABBY MANAGEMENT, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013497
Total Value
$76.9M
Positions
27
Other Managers
1
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 464287955 | 1,190 | $26.3M | 34.19% |
| 2 | SPDR S&P 500 ETF | SPY | 264 | $15.5M | 20.12% |
| 3 | CORE SCIENTIFIC INC | 21874A956 | 7,513 | $10.6M | 13.72% |
| 4 | ISHARES TR | 464287905 | 237 | $5.2M | 6.81% |
| 5 | EOS ENERGY ENTERPRISES | EOSE | 853,365 | $4.1M | 5.39% |
| 6 | EOS ENERGY ENTERPRISES | EOSE | 5,265 | $2.6M | 3.33% |
| 7 | SPDR S&P 500 ETF | SPY | 3,280 | $1.9M | 2.50% |
| 8 | ISHARES TR | 464287655 | 7,940 | $1.8M | 2.28% |
| 9 | VIVANI MEDICAL INC | VANI | 1,311,439 | $1.5M | 1.98% |
| 10 | BIT DIGITAL INC | BTBT | 475,451 | $1.4M | 1.81% |
| 11 | SPDR S&P 500 ETF | SPY | 21 | $1.2M | 1.60% |
| 12 | BIT DIGITAL INC | BTBT | 3,502 | $1.0M | 1.33% |
| 13 | EOS ENERGY ENTERPRISES | EOSE | 1,735 | $843,210 | 1.10% |
| 14 | REVIVA PHARMACEUTCLS HLDGS INC | 76152G950 | 3,831 | $693,411 | 0.90% |
| 15 | CHECKPOINT THERAPEUTICS INC | 162828956 | 1,804 | $577,280 | 0.75% |
| 16 | CORE SCIENTIFIC INC | 21874A106 | 23,559 | $331,004 | 0.43% |
| 17 | CEL-SCI CORP | CVM | 711,735 | $284,623 | 0.37% |
| 18 | VOLCON INC | EMPD | 54,574 | $238,488 | 0.31% |
| 19 | LICHEN CHINA LTD | G5479G108 | 1,257,112 | $223,263 | 0.29% |
| 20 | UNIVERSE PHARMACEUTICALS INC | UPC | 333,355 | $203,347 | 0.26% |
| 21 | ZEVRA THERAPEUTICS INC | ZVRA | 163 | $135,942 | 0.18% |
| 22 | LOGICMARK INC | LGMK | 82,214 | $123,321 | 0.16% |
| 23 | HEALTHY CHOICE WELLNESS CORP | HCWC | 49,011 | $57,828 | 0.08% |
| 24 | CN ENERGY GROUP INC | CNEY | 92,977 | $29,288 | 0.04% |
| 25 | DIGITAL ALLY INC | 25382T200 | 54,644 | $28,704 | 0.04% |
| 26 | FOXO TECHNOLOGIES INC | FOXOW | 80,561 | $23,467 | 0.03% |
| 27 | 60 DEGREES PHARMACEUTICALS INC | SXTPW | 161,930 | $4,809 | 0.01% |